Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

Eli Lilly total long term liabilities for the quarter ending September 30, 2024 were $36.612B, a 48.77% increase year-over-year.

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.

Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B